NOVEL INHIBITOR FOR ADVANCED GLYCATION ENDPRODUCT FORMATION AND ALDOSE REDUCTASE INHIBITOR

摘要

It is intended to provide an advanced glycation endproduct (AGE) formation inhibitor, which also serves as an aldose reductase inhibitor, usable in simultaneously treating and preventing various diseases relating to the AGE formation such as diabetes and various diseases relating to aldose reductase inhibition; and drugs, compositions, foods and drinks containing the same as the active ingredient. Namely, drugs, compositions, foods and drinks containing anthocyanin which is obtained by concentrating or extracting a plant material or the like and is useful as an AGE formation inhibitor as well as an aldose reductase inhibitor.